Induction Healthcare Group PLC Update on publication of Audited Final Results (7893D)
24 October 2022 - 5:00PM
UK Regulatory
TIDMINHC
RNS Number : 7893D
Induction Healthcare Group PLC
24 October 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Update on publication of Audited Final Results
Induction (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces that its
audited final results for the year ended 31 March 2022 will now be
released on or before Monday 28 November 2022. This is as a result
of staff shortages at the Company's auditor and following the
unexpected bereavement of a family member of one of the Company's
Board.
There is no change to the financial performance and, as
previously reported on 22 September , results for FY22 are expected
to be in-line with guidance.
Induction will announce its interim results for the six months
ended 30 September 2022 shortly after the publication of the 2022
audited results.
During November, the Board expect to issue a trading update on
the six-month period to 30 September 2022.
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
James Balmain, Chief Executive Officer
Guy Mitchell, Chief Financial Officer
Singer Capital Markets (Nominated
Adviser and Broker) +44 (0)20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd induction@walbrookpr.com
Alice Woodings Mob: +44 (0)7407 804 654
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software
solutions through a single integrated platform that transforms care
delivery. Our system-wide applications help healthcare providers
and administrators to deliver care at any stage remotely as well as
face-to-face - giving the communities they serve greater
flexibility, control and ease of access. Purpose-built for
integration with leading Electronic Medical Record (EMR) platforms,
our products offer immediate stand-alone value that becomes even
greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as
well non-health government services, our applications are relied
upon by hundreds of thousands of clinicians and millions of
patients across almost every hospital in the British Isles.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDMZMZGKFKGZZM
(END) Dow Jones Newswires
October 24, 2022 02:00 ET (06:00 GMT)
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jul 2023 to Jul 2024